Rare heart condition triggered by Covid vaccine is ‘mild and resolves quickly’, say scientists

A rare heart-related health condition induced by the Covid-19 vaccine is mild and resolves quickly, according to scientists.

Myocarditis is a condition which is characterised by inflamed cardiac muscle and can weaken the flow of blood around the body. The most common cause is infection and in those cases it can be serious, and even fatal.

Data show that coronavirus vaccines increase the risk of a person developing myocarditis, with the risk highest in young boys and after the second dose.

A group of experts from across the US reviewed 139 cases of vaccine-induced myocarditis from across the US in

Read More

More states allow COVID vaccine boosters for all adults

Health authorities in Arkansas said on Monday they would broaden eligibility for COVID-19 vaccine booster shots to all adults, as a growing list of state and local officials look for ways to accelerate third doses in hopes of heading off a potential new wave of the virus.

“For Pfizer and Moderna, those who are 18 and over, go get the shot. There’s not any limitations on that. Obviously you should be six months after the second shot. But we want you to get the booster,” Arkansas Governor Asa Hutchinson told reporters on Monday.

That’s a significant expansion beyond the

Read More

French health authority advises against Moderna COVID-19 vaccine for under 30s

PARIS (Reuters) -France’s public health authority has recommended people under 30 be given Pfizer’s Comirnaty COVID-19 vaccine when available instead of Moderna Inc’s Spikevax jab, which carried comparatively higher risks of heart-related problems. 

  The Haute Autorite de Sante (HAS), which does not have legal power to ban or licence drugs but acts as an advisor to the French health sector, cited “very rare” risks linked to Myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday. 

  “Within the population aged under 30, this risk appears to be

Read More

What heart and stroke patients should know about COVID-19 vaccine boosters

vaccine
Credit: Unsplash/CC0 Public Domain

COVID-19 vaccines offer protection against life-threatening disease caused by the coronavirus to people with heart disease and stroke, and a booster dose could bolster that protection, health experts said.

The Centers for Disease Control and Prevention, which sets policy on vaccine use, recommended Pfizer booster vaccines for several groups last week. People 65 and older; residents in long-term care settings; and people 50 and older with underlying medical conditions should receive a booster at least six months after their initial Pfizer vaccine doses, the CDC said.

People 18 to 49 with underlying medical conditions and adults

Read More

U.S. officials probe whether Moderna vaccine is linked to higher risk of uncommon side effect

Federal health officials are investigating emerging reports that the Moderna coronavirus vaccine may be associated with a higher risk of a heart condition called myocarditis in younger adults than previously believed, according to two people familiar with the review who emphasized the side effect still probably remains uncommon.

The investigation, which involves the Food and Drug Administration and the Centers for Disease Control and Prevention, is focusing on Canadian data that suggests the Moderna vaccine may carry a higher risk for young people than the Pfizer-BioNTech vaccine, especially for males below the age of 30 or so. The authorities also

Read More

3rd COVID vaccine dose recommended for heart transplant patients | WWTI

(WWTI) — Health officials from across the country are recommending a third dose of the COVID-19 vaccine for some patients with weakened immune systems.

The American Heart Association and American Stroke Association is recommending a third dose of the COVID-19 vaccine for heart transplant patients and those with weakened immune systems. This recommendation was issued in a joint statement from the two organizations.

Recently, the U.S. Centers for Disease Control and Prevention recommended a third dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine for people with moderately to severely

Read More